BlackRock Inc. - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$748,277,000
+1.2%
4,949,917
-2.4%
0.02%
+4.2%
Q2 2022$739,053,000
+33.8%
5,072,075
+8.9%
0.02%
+60.0%
Q1 2022$552,163,000
-13.6%
4,656,866
+0.5%
0.02%
-6.2%
Q4 2021$638,787,000
-0.2%
4,635,280
+0.6%
0.02%
-11.1%
Q3 2021$639,967,000
+40.5%
4,607,073
-1.8%
0.02%
+38.5%
Q2 2021$455,460,000
+76.1%
4,691,578
+24.0%
0.01%
+62.5%
Q1 2021$258,608,000
-14.4%
3,783,554
+7.3%
0.01%
-20.0%
Q4 2020$302,125,000
+34.8%
3,524,951
+2.2%
0.01%
+25.0%
Q3 2020$224,190,000
-13.2%
3,448,540
-2.3%
0.01%
-20.0%
Q2 2020$258,176,000
+131.9%
3,531,326
+8.0%
0.01%
+100.0%
Q1 2020$111,318,000
-29.9%
3,271,169
+12.1%
0.01%
-16.7%
Q4 2019$158,873,000
+31.2%
2,918,341
+0.6%
0.01%
+20.0%
Q3 2019$121,077,000
+11.0%
2,902,123
+16.5%
0.01%0.0%
Q2 2019$109,059,000
-25.9%
2,490,520
-12.9%
0.01%
-28.6%
Q1 2019$147,149,000
+66.3%
2,858,893
+19.5%
0.01%
+75.0%
Q4 2018$88,499,000
+8.7%
2,393,148
+10.4%
0.00%0.0%
Q3 2018$81,400,000
-1.5%
2,167,762
+3.7%
0.00%0.0%
Q2 2018$82,613,000
+69.8%
2,090,388
+10.7%
0.00%
+100.0%
Q1 2018$48,650,000
+56.2%
1,888,608
+63.6%
0.00%
+100.0%
Q4 2017$31,139,000
-27.0%
1,154,207
+1.1%
0.00%
-50.0%
Q3 2017$42,676,000
+67.2%
1,141,702
+11.8%
0.00%
+100.0%
Q2 2017$25,523,0001,020,9320.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q2 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 490,422$12,755,87613.24%
FNY Investment Advisers, LLC 30$00.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders